Filing Flows › CareDx (CDNA) › Q1 2026
CareDx (CDNA) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 28, 2026
CareDx (CDNA) reported revenue of $118M for the first quarter 2026 (Q1 2026), +39% from a year earlier and +9% from the quarter before. Operating margin was 1.0%, net earnings $2.8M (2.4% of revenue).
CareDx, Q1 2026: revenue $118M (+39% year over year), operating margin 1.0%, net earnings $2.8M, operating cash flow $4.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $118M | +9% | +39% |
| Operating profit | $1.2M | — | — |
| Net earnings | $2.8M | — | — |
| Operating cash flow | $4.3M | -80% | — |
| Free cash flow | $514K | — | — |
What changed
Revenue was $117.7M in Q1 2026, up 39% year over year and up 9% from the previous quarter. Testing services revenue was the largest line at 78% of revenue. Testing services revenue added $29.5M year over year (up 48%), 89% of the total change. Product revenue declined 4%.
Operating profit was $1.2M, a 1.0% margin (up 16.8 points year over year). Total costs grew 19% against revenue growth of 39%. The fastest-growing cost line was General & admin (+34%). Net earnings were $2.8M. The effective tax rate was -1.2%. Non-operating items added $1.6M, 57% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $4.3M, 154% of net earnings. Non-cash charges added back $3.9M of depreciation and amortization and $9.8M of share-based compensation. Working capital and other items used $12.2M. Capital expenditures of $3.8M left free cash flow of $514K.
Questions
What was CareDx's revenue in the first quarter 2026?
CareDx (CDNA) reported revenue of $118M for the first quarter 2026 (Q1 2026), +39% from a year earlier and +9% from the quarter before.
Was CareDx profitable in the first quarter 2026?
Operating profit was $1.2M (1.0% of revenue) and net earnings $2.8M.
Source: CareDx 10-Q on SEC EDGAR.